Snake venom hyaluronidase: A therapeutic target

Cell Biochemistry and Function

Volumn 24, Issue 1, 2006, Pages 7-12

  Kemparaju, K ^a   Girish, K S ^a,b  

^a UNIVERSITY OF MYSORE   (India)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Extracellular matrix; Hyaluronic acid; Hyaluronidase; Snake venom; Spreading factor

Indexed keywords

HYALURONIC ACID; HYALURONIDASE; ISOENZYME; SNAKE VENOM; TOXIN;

DEGRADATION; DIFFUSION; ENVENOMATION; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; REVIEW; SNAKEBITE; TISSUE INJURY;

ANIMALS; ANTIVENINS; EXTRACELLULAR MATRIX; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; SNAKE BITES; SNAKE VENOMS;

EID: 31644442036     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1261     Document Type: Review

References (94)

1. Aird SD. Ophidian envenomation strategies and the role of purines. Toxicon 2002; 40: 335-393.
2. Chippaux JP, Williams, White J. Snake venom variability: methods of study results and interpretations. Toxicon 1991; 29: 1279-1303.
3. Tu AT. Overview of snake venom chemistry. Adv Exp Med Biol 1996; 39: 37-62.
4. 2 Enzymes: Structure, Function and Mechanism. J Wiley: New York, 1997.
5. Shashidhara Murthy R, Jagadeesha DK, Girish KS, Kemparaju K. Variation in biochemical and pharmacological properties of Indian cobra (Naja naja) venom due to geographical distribution. Mol Cell Biochem 2002; 229: 93-101.
6. Cher CD, Armugam A, Zhu YZ, Jeyaseelan K. Molecular basis of cardiotoxicity upon cobra envenomation. Cell Mol Life Sci 2005; 62: 105-118.
7. Girish KS, Jagadeesha DK, Rajeev KB, Kemparaju K. Snake venom hyaluronidase: an evidence for isoforms and extracellular matrix degradation. Mol Cell Biochem 2002; 240: 105-110.
8. Girish KS, Shashidharamurthy R, Nagaraju S, Gowda TV, Kemparaju K. Isolation and characterization of hyaluronidase a 'spreading factor' from Indian cobra (Naja naja) venom. Biochimie 2004; 86: 193-202.
9. Girish KS, Kemparaju K. A low molecular weight isoform of hyaluronidase: purification from Indian cobra (Naja naja) venom and partial characterization. Biochemistry (Moscow), 2005; (in press).
10. Yingprasertchai S, Bunyasrisawt S, Ratanabanangkoon K. Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms. Toxicon 2003; 42: 635-646.
11. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992; 6: 2397-2404.
12. Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: its nature, distibution, function and turnover. J Intern Med 1997; 242: 27-33.
13. Toole BP. Hyaluronan is not just a goo. J Clin Invest 2000; 106: 335-336.
14. Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem 1934; 107: 629-634.
15. Meyer K, Palmer JW and with the assistance of Smyth EM. On glycoproteins II the polysaccharides of vitreous humor and of umbilical cord. J Biol Chem 1936; 114: 689-703.
16. Laurent TC (ed.). The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives. Portland Press: London, 1998
17. Matsushita O, Okabe A. Clostridial hydrolytic enzymes degrading extracellular components. Toxicon 2001; 39: 1769-1780.
18. Toole BP. Hyaluronan. In Proteoglycans: Structure, Biology and Molecular Interactions, Lozzo RV (ed.). Marcel Dekker: New York, USA.
19. Reed RK, Lilja K, Laurent TC. Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand 1988; 134: 405-411.
20. Shiedlin A, Bigelow R, Christopher W, et al. Evaluation of hyaluronan from different sources: Streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules 2004; 5: 2122-2127.
21. Adamia S, Maxwell CA, Pilarski LM. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 2005; 5: 3-14.
22. DeAngelis PL. Hyaluronan synthases: fascinating glycosyl-transferases from vertebrates, bacterial pathogens and algal viruses. Cell Mol Life Sci 1999; 56: 670-682.
23. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem 1997; 272: 13997-14000.
24. Itano N, Kimata K. Mammalian hyaluronan synthases. IUBMB Life 2002; 54: 195-199.
25. Itano N, Sawai T, Yoshida M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999; 274: 25085-25092.
26. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem J 1984; 220: 597-600.
27. Spicer AP, McDonald JA. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem 1998; 273: 1923-1932.
28. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet?. Glycobiology 2003; 13: 105R-115R.
29. Menzel EJ, Fair C. Hyaluronidase and its substrate hyaluronan: Biochemistry, biological activities and therapeutic uses. Cancer Lett 1998; 131: 3-11.
30. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 2002; 277: 4593-4596.
31. Prehm P. Cellular functions of hyaluronate. In Basic Aspects of Glaucoma Research III, Lutohen-Drecoll E (ed.). Stuttgart, New York, 1993; 31-52.
32. Heldin P. Importance of hyaluronan biosynthesis and degradation in cell differentiation and tumor formation. Braz J Med Biol Res 2003; 36: 967-973.
33. Toole BP. Glycosaminoglycans in morphogenesis. In Cell Biology of the Extracellular Matrix, Hay ED (ed.). Plenum Publishing Corp: New York, 1991; 1384-1386.
34. Laurich C, Wheeler MA, Iida J, Neudauer CL, McCarthy JB, Bullard KM. Hyaluronan mediates adhesion of metastatic colon carcinoma cells. J Surg Res 2004; 122: 70-74.
35. Termeer CC, Sleeman JP, Simon JC. Hyaluronan-magic glue for the regulation of the immune response?. Trends Immunol 2003; 24: 112-114.
36. George J, Stern R. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin Chem Acta 2004; 348: 189-197.
37. West DC, Chen WJ, Abatangelo G. Function of HA in wound repair. Wound Rep Reg 1999; 7: 79-89.
38. Toole BP, Hascall VC. Hyaluronan and tumor growth. Am J Pathol 2002; 161: 745-747.
39. Lokeshwar VB, Lokeshwar BL, Pham HT, Block NL. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res 1996; 56: 651-657.
40. Toole BP. Hyaluronan. from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528-539.
41. Camenisch TD, McDonald JA. 'Hyaluronan' is bigger better? Am J Respir Cell Mol Biol 2000; 23: 431-433.
42. Lee JY, Spicer AP. Hyaluronan: a multifunctional, megadaton, stealth molecule. Curr Opin Cell Biol 2000; 12: 581-586.
43. Gregory FI, Tony C, Stern R. The hyaluronidases: a chemical, biological and clinical overview. Trends Glycosc Glycotechnol 1996; 8: 419-434.
44. Csoka TB, Frost GI, Stern R. Hyaluronidases in tissue invasion. Invas Metasta 1997; 17: 297-311.
45. De Assis CM, Gandra RF, Gambale W, Shimizu MT, Paula CR. Biosynthesis of chondroitinase and hyaluronidase by different strains of Paracoccidioides brasiliensis. J Med Microbiol 2003; 52: 479-481.
46. Shimuzu MT, Almeida NQ, Fantinato V, Unterkircher CS. Studies on hyaluronidase, chondroitin sulphatase, protease and phospholipase secreated by candida species. Mycoses 1996; 39: 161-167.
47. Hynes W, Walton S. Hyaluronidases of Gram-positive bacteria. FEMS Microbiol Lett 2000; 183: 201-207.
48. Sutherland IW. Polysaccharide lyases: FEMS Microbiol REV 1995; 16: 323-347.
49. Ponnuraj K, Jedrzejas MJ. Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 Å resolution. J Mol Biol 2000; 299: 885-895.
50. Baker JR, Dong S, Pritchard DG. The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem J 2002; 365: 317-322.
51. Allen AG, Lindsay H, Seilly D, Bolitho S, Peters SE, Maskell DJ. Identification and characterisation of hyaluronate lyase from Streptococcus suis. Microb Pathog 2004; 36: 327-335.
52. Makris G, Wright JD, Ingham E, Holland KT. The hyaluronate lyase of Staphylococcus aureus-a virulence factor? Microbiology 2004; 150: 2005-2013.
53. Hotez P, Cappello M, Hawdon J, Beckers C, Sakanari J. Hyaluronidases of the gastrointestinal invasive nematodes Ancylostoma canium and Anisakis simplex: possible functions in the pathogenesis of human zoonoses. J Infect Dis 2000; 170: 918-926.
54. Hovingh P, Linker A. Hyaluronidase activity in leeches (Hirudinea). Comp Biochem Physiol B Biochem Mol Biol 1999; 124: 319-326.
55. Pukrittayakamee S, Warrell DA, Desakorn V, McMichael AJ, White NJ, Bunnag D. The hyaluronidase activities of some Southeast Asian snake venoms. Toxicon 1988; 26: 629-637.
56. Tan N, Tan C. Comparative study of cobra (Naja) venom enzymes. Comp Biochem Physiol 1988; 90B: 745-750.
57. Xu X, Wang X, Xi X, Liu J, Huang J, Lu Z. Purification and partial characterization of hyaluronidase from five pace snake (Agkistrodon acutus) venom. Toxicon 1982; 20: 973-981.
58. Kudo K, Tu AT. Characterization of hyaluronidase isolated from Agkistrodon contortrix contortrix (Southern Copperhead) venom. Arch Biochem Biophys 2001; 386: 154-162.
59. Ramanaiah M, Parthasarathy PR, Venkaiah B. Isolation and characterization of hyaluronidase from scorpion (Heterometrus fulvipes) venom. Biochem Int 1990; 20: 301-310.
60. Pessini AC, Takao TT, Cavalheiro EC, et al. A hyaluronidase from Tityus serrulatus scorpion venom: isolation, characterization and inhibition by flavonoids. Toxicon 2001; 39: 1495-1504.
61. Gmachl M, Kreil G. Bee venom hyaluronidase is homologous to a membrane protein of mammilian sperm. Proc Natl Acad Sci USA 1993; 90: 3569-3573.
62. Markovic-Housley Z, Miglierini G, Soldatova L, Rizkallah PJ, Muler U, Schirmer T. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure Fold Des 2000; 8: 1025-1035.
63. Kreil G. Hyaluronidases-a group of neglected enzymes. Protein Sci 1995; 4: 1666-1669.
64. Lu G, Kochoumian L, King TP. Sequence identity and antigenic cross reactivity of white face hornet venom allergen, also a hyaluronidase, with other proteins. J Biol Chem 1995; 270: 4457-4465.
65. Wright P, Elgert KD, Campbell BJ, Barrett JT. Hyaluronidase and esterase activities of the venom of the poisonous brown recluse spider. Arch Biochem Biophys 1973; 159: 415-426.
66. Schanbacher FL, Lee CK, Wilson IB, Howell DE, Odell GV. Purification and characterization of tarantula Dugesiella hentzi (Girard) venom hyaluronidase. Comp Biochem Physiol 1973; 44B: 389-396.
67. Rash LD, Hodgson WC. Pharmacology and biochemistry of spider venoms. Toxicon 2002; 40: 225-254.
68. Barbara KC, Knysak I, Martins R, Hogan C, Winkel K. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 2005; 45: 489-499.
69. da C B Gouveia AI, da Silveira RB, Nader HB, Dietrich CP, Gremski W, Veiga SS. Identification and partial characterisation of hyaluronidases in Lonomia obliqua venom. Toxicon 2005; 45: 403-410.
70. Poh CH, Yuen R, Chung MC, Khoo HE. Purification and partial characterization of hyaluronidase from Stone fish (Synanceja horrida) venom. Comp Biochem Physiol (B) 1992; 101: 159-163.
71. Ng HC, Ranganathan S, Chua KL, Khoo HE. Cloning and molecular characterization of the first aquatic hyaluronidase, SFHYA1, from the venom of stonefish (Synanceja horrida). Gene 2005; 346: 71-81.
72. Tu AT, Hendon RR. Characterization of lizard venom hyaluronidase and evidence for its action as a spreading factor. Comp Biochem Physiol 1983; 76B: 337-383.
73. Meyer K. Hyaluronidases. In Enzymes, Boyer PD (ed.). Academic Press: New York, 1971; 307-320.
74. Saitoh H, Takagaki K, Majima M, et al. Enzymatic reconstruction of glycosaminoglycan oligosaccharide chains using the transglycosylation reaction of bovine testicular hyaluronidase. J Biol Chem 1995; 270: 3741-3747.
75. Rigden DJ, Galperin MY, Jedrzejas MJ. Analysis of structure and function of putative surface-exposed proteins encoded in the Streptococcus pneumoniae genome: a bioinformatics-based approach to vaccine and drug design. Crit Rev Biochem Mol Biol 2003; 38: 143-168.
76. Rigden DJ, Jedrzejas MJ, deMello LV. Identification and analysis of catalytic TIM barrel domains in seven further glycoside hydrolase families. FEBS Lett 2003; 544: 103-111.
77. Hofman DC, Duran-Reynals F. The influence of testicle extract on the intradermal spread of injected fluids and particles. J Exp Med 1931; 53: 387-398.
78. Duran-Reynals F. Studies on a certain spreading factor existing in bacteria and its significance for bacterial invasiveness. J Exp Med 1933; 58: 161-181.
79. Smith KJ, Skelton HG, Turiansky G, Wager KF. Hyaluronidase enhances the therapeutic effect of vinblastine in intra-lesional treatment of Kaposi's sarcoma. J Am Acad Dermatol 1986; 36: 239-242.
80. Kemeny DM, Dalton N, Lawrence AJ, Pearce FL, Vernon CA. The purification and characterization of hyaluronidase from the venom of the honeybee, Apis mellifera. Eur J Biochem 1984; 139: 217-223.
81. Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 1998; 77: 396-401.
82. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002; 21: 25-29.
83. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 2004; 83: 317-325.
84. Lomonte B, Leon G, Hanson LA. Similar effectiveness of Fab and F(ab′)2 antivenoms in neutralization of hemorrhagic activity of Vipera berus snake venom in mice. Toxicon 1996; 34: 1197-1202.
85. 2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 1997; 35: 1627-1637.
86. 2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom. Am J Trop Med Hyg 1999; 61: 266-271.
87. Leon G, Valverde JM, Rojas G, Lomonte B, Gutierrez JM. Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 2000; 38: 233-244.
88. Guitterez JM, Leon G, Rojas G, Lomante B, Rucavado A, Chaves F. Neutralization of local tissue damage induced by Bothrops asper (Terciopelo) snake venom. Toxicon 1998; 36: 1529-1538.
89. Girish KS, Mohanakumari HP, Nagaraju S, Vishwanath BS, Kemparaju K. Hyaluronidase and protease activities from Indian snake venoms: neutralization by Mimosa pudica root extract. Fitoterapia 2004; 75: 378-380.
90. Kuppusamy UR, Das NP. Inhibitory effects of flavonoids on several venom hyaluronidases. Experentia 1991; 47: 1196-1200.
91. Girish KS, Kemparaju K. Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides. Biochemistry (Moscow) (in press).
92. Anai K, Sugiki M, Yoshida E, Maruyama M. Neutralization of a snake venom haemorrhagic metalloproteinase prevents coagulopathy after subcutaneous injection of Bothrops jararaca venom in rats. Toxicon 2002; 40: 63-68.
93. Escalante T, Franceschi A, Rucavado A, Gutierrez JM. Effectiveness of Batimastat: a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1: a hemorrahagic metalloproteinase from the venom of Bothrops asper. Biochem Pharmacol 2000; 60: 269-274.
94. 2EDTA. Am J Trop Med Hyg 2002; 63: 313-319.